Table 3.
KEGG pathway analysis of differentially expressed genes associated with hepatocellular carcinoma.
Category | Term | Count | % | P value | Genes | FDR |
---|---|---|---|---|---|---|
Downregulated DEGs | hsa04978: mineral absorption | 9 | 0.03 | 2.22E − 07 | MT1M, SLC5A1, MT2A, MT1E, TRPV6, MT1H, MT1X, MT1G, and MT1F | 2.68E − 04 |
hsa00830: retinol metabolism | 10 | 0.03 | 2.90E − 07 | CYP3A4, CYP4A11, CYP2B6, CYP2C8, ADH4, ADH1B, CYP26A1, CYP2A6, CYP1A2, and RDH16 | 3.50E − 04 | |
hsa00232: caffeine metabolism | 4 | 0.01 | 2.79E − 05 | XDH, NAT2, CYP2A6, and CYP1A2 | 0.03 | |
hsa00982: drug metabolism-cytochrome P450 | 8 | 0.03 | 4.75E − 05 | CYP3A4, CYP2B6, CYP2C8, ADH4, ADH1B, CYP2A6, CYP2E1, and CYP1A2 | 0.06 | |
hsa05204: chemical carcinogenesis | 8 | 0.03 | 1.35E − 04 | CYP3A4, CYP2C8, ADH4, NAT2, ADH1B, CYP2A6, CYP2E1, and CYP1A2 | 0.16 | |
| ||||||
Upregulated DEGs | hsa04110: cell cycle | 8 | 0.05 | 9.30E − 07 | CCNB1, CDK1, CCNB2, BUB1, TTK, PTTG1, SFN, and CDC25C | 9.18E − 04 |
hsa04115: p53 signaling pathway | 6 | 0.04 | 1.03E − 05 | CCNB1, CDK1, CCNB2, RRM2, SFN, and GTSE1 | 0.01 | |
hsa04914: progesterone-mediated oocyte maturation | 5 | 0.03 | 5.69E − 04 | CCNB1, CDK1, CCNB2, BUB1, and CDC25C | 0.56 | |
hsa04114: oocyte meiosis | 4 | 0.03 | 0.01 | CDK1, BUB1, PTTG1, and CDC25C | 11.64 |
KEGG: Kyoto Encyclopedia of Genes and Genomes; FDR: false discovery rate.